These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24367530)

  • 1. The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature.
    Pease M; Ling C; Mack WJ; Wang K; Zada G
    PLoS One; 2013; 8(12):e82619. PubMed ID: 24367530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
    J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms of tumorigenesis.
    Farrell WE
    Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
    Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of genetic and epigenetic changes in pituitary tumorigenesis.
    Fukuoka H; Takahashi Y
    Neurol Med Chir (Tokyo); 2014; 54(12):943-57. PubMed ID: 25446387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.
    Ling C; Pease M; Shi L; Punj V; Shiroishi MS; Commins D; Weisenberger DJ; Wang K; Zada G
    PLoS One; 2014; 9(4):e96178. PubMed ID: 24781529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
    Zhu X; Lee K; Asa SL; Ezzat S
    Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
    Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
    Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.
    Ron-Bigger S; Bar-Nur O; Isaac S; Bocker M; Lyko F; Eden A
    Stem Cells; 2010 Aug; 28(8):1349-54. PubMed ID: 20572015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.
    Ezzat S; Cheng S; Asa SL
    Mol Cell Endocrinol; 2018 Jul; 469():70-76. PubMed ID: 28711607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling and histone modifications in pituitary tumors.
    Tateno T; Zhu X; Asa SL; Ezzat S
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
    Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas.
    Augello C; Gregorio V; Bazan V; Cammareri P; Agnese V; Cascio S; Corsale S; Calò V; Gullo A; Passantino R; Gargano G; Bruno L; Rinaldi G; Morello V; Gerbino A; Tomasino RM; Macaluso M; Surmacz E; Russo A
    J Cell Physiol; 2006 Jun; 207(3):654-9. PubMed ID: 16447252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation association with stage progression of head and neck squamous cell carcinoma.
    Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A
    Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.